DoseRoutine supplement library logoDoseRoutine
Isotretinoin softgel capsules on a matte clinical surface
DoseRoutine Isotretinoin — Isotretinoin softgel capsules on a matte clinical surface. Original DoseRoutine photography.
medicationPrescription only (US)Oral isotretinoin (Accutane and generics) is FDA-approved for severe recalcitrant nodular acne and is dispensed only through the iPLEDGE risk-management program because of teratogenicity

IsotretinoinBenefits, Dosage & Interactions

Also known as: Accutane

Isotretinoin, originally sold as Accutane and now as Absorica, Claravis and others, is an oral retinoid for severe nodular or treatment-resistant acne. It shrinks sebaceous glands and reduces oil output, and courses typically run four to six months aiming at a cumulative target.

How much Isotretinoin do people take?

The Cochrane review's included dose-comparison trials studied continuous low-dose (0.25–0.4 mg/kg/day), continuous conventional-dose (0.5–1 mg/kg/day), and intermittent (one week per month) oral isotretinoin regimens; the antihistamine-adjuvant trial dosed isotretinoin without specifying a fixed mg/kg figure in the abstract. Route reported: Oral capsule in all cited trials. Frequency reported: Once or twice daily depending on regimen, with one comparison arm limited to one week per month. These are amounts documented in the cited studies and labels for Isotretinoin — they are reported for reference, not a recommendation. Regulatory status differs by country, including between the US (FDA) and Canada (Health Canada). Confirm any amount with a licensed clinician before you take it.

See the full reported protocol and its sources

Researched by DoseRoutine Research TeamReviewed for accuracy by Nicholas Alexander, RSE, SO, PMPLast updated Educational reference only — not medical advice. Always confirm dosing and safety decisions with a licensed clinician.

Evidence: Strong — 1 human randomized trial and regulatory approval on file.
Evidence strengthStrong · 4/4
PreclinicalStrong human evidence

1 human randomized trial and regulatory approval on file.

Chemical structure of Isotretinoin (PubChem CID 5282379)
Structure via PubChem

Quick answer

Isotretinoin, originally sold as Accutane and now as Absorica, Claravis and others, is an oral retinoid for severe nodular or treatment-resistant acne. It shrinks sebaceous glands and reduces oil output, and courses typically run four to six months aiming at a cumulative target. It is strictly controlled because it causes severe birth defects, requiring the iPLEDGE program in the United States.

Class
Oral retinoid (vitamin A derivative)
Brand names
Accutane (discontinued), Absorica, Claravis, Amnesteem, Myorisan
Typical course
About 4–6 months, guided by a cumulative target
Pregnancy
Absolutely contraindicated; iPLEDGE enrollment required in the U.S.
Expected effects
Dry lips, dry skin and eyes, nosebleeds, sun sensitivity
Monitoring
Pregnancy tests, liver enzymes and lipids during treatment

Compiled by DoseRoutine from public sources including NIH/MedlinePlus, the FDA label, Mayo Clinic and PubChem. Educational information, not medical advice.

Plasma half-life
10–20 h
Typical timing
with a meal
Food rule
with food
Default unit
mg

What published protocols report

Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.

Reported amounts
The Cochrane review's included dose-comparison trials studied continuous low-dose (0.25–0.4 mg/kg/day), continuous conventional-dose (0.5–1 mg/kg/day), and intermittent (one week per month) oral isotretinoin regimens; the antihistamine-adjuvant trial dosed isotretinoin without specifying a fixed mg/kg figure in the abstract[1][2]
Route studied
Oral capsule in all cited trials[1][2]
Frequency
Once or twice daily depending on regimen, with one comparison arm limited to one week per month[1][2]
Cycle length
Included trials in the Cochrane review ran from 8 to 32 weeks (mean 19.7 weeks) of therapy; the antihistamine-adjuvant trial assessed outcomes over 12 weeks[1][2]

Reported for Isotretinoin in the cited sources. Published ranges are not dosing advice.

References & evidence

Documents the Isotretinoin entry is written from. Each number matches an inline marker above.

  1. [1]Oral isotretinoin for acneCosta CS, Bagatin E, Martimbianco ALC, da Silva EM, Lúcio MM, Magin P, Riera R · Cochrane Database of Systematic Reviews · 2018 · Peer-reviewed · PMID 30484286
  2. [2]Effect of antihistamine as an adjuvant treatment of isotretinoin in acne: a randomized, controlled comparative studyLee HE, Chang IK, Lee Y, Kim CD, Seo YJ, Lee JH, Im M · Journal of the European Academy of Dermatology and Venereology · 2014 · Peer-reviewed · PMID 25081735

References & Evidence

Sources on this page that document Isotretinoin dosing, timing and safety.

  1. [1]U.S. National Library of Medicine View source
  2. [2]National Center for Biotechnology Information View source

Educational information only — not medical advice. Dose ranges vary by person, indication and prescriber.

What is Isotretinoin?Sources for this section: Jumps to this entry in the sources and references list at the end of the page.

Isotretinoin is an oral retinoid medication primarily used for severe, recalcitrant nodular acne that has not responded to other treatments, including oral antibiotics. It is derived from vitamin A and works by significantly reducing the size and activity of sebaceous glands, thereby decreasing sebum production (NIH ODS). Isotretinoin also has anti-inflammatory properties and helps normalize follicular keratinization, preventing the formation of comedones. Due to its potent effects and significant potential for adverse effects, isotretinoin is a highly regulated medication and requires strict monitoring by a healthcare professional. It is available under various brand names, though Accutane, one of the original brands, has been discontinued (FDA label).

What does the research say about Isotretinoin?

Tap a section to expand.

Isotretinoin's primary mechanism of action involves reducing the size and activity of sebaceous glands, leading to a substantial decrease in sebum production. Sebum is an oily substance produced by the skin's glands, and its overproduction is a key factor in the development of acne. By reducing sebum, isotretinoin creates an environment less conducive to the growth of *Propionibacterium acnes* (now known as *Cutibacterium acnes*), a bacterium implicated in acne (PubChem). Beyond its effect on sebum, isotretinoin also modifies follicular keratinization, meaning it helps normalize the shedding of skin cells within hair follicles, which prevents them from becoming clogged and forming comedones (blackheads and whiteheads). Additionally, it possesses anti-inflammatory properties that reduce the redness and swelling associated with acne lesions (DrugBank). The exact molecular pathways involved are complex but include interaction with retinoid acid receptors in cells.

Source for this section: Sources for How does Isotretinoin work?: Jumps to this entry in the sources and references list at the end of the page.

The primary benefit of isotretinoin is its effectiveness in treating severe, recalcitrant nodular acne. For individuals with severe acne that has not responded to other therapies, isotretinoin can lead to substantial and often long-lasting improvement or complete clearance of acne lesions (Cochrane, 2018 review). It significantly reduces the number and severity of inflammatory lesions (papules, pustules, cysts, and nodules) and non-inflammatory lesions (comedones). Beyond the physical improvement in skin appearance, successful treatment with isotretinoin can lead to significant psychosocial benefits, including improved self-esteem, reduced anxiety, and a better quality of life for individuals severely affected by acne (Mayo Clinic). Its long-term efficacy often means that patients do not require further acne treatment after completing a course.

Numerous studies and clinical reviews support the efficacy of isotretinoin for severe acne. A Cochrane review published in 2018, which analyzed several randomized controlled trials, concluded that isotretinoin is an effective treatment for severe acne, often leading to complete or near-complete remission. The review highlighted its superior efficacy compared to oral antibiotics or topical treatments for severe cases. The FDA label for isotretinoin details its approval based on clinical trials demonstrating significant reductions in inflammatory nodule counts. Long-term follow-up studies, such as those referenced by the American Academy of Dermatology, confirm the sustained benefits in many patients after completing a course of isotretinoin, with a significant number experiencing prolonged remission. Evidence consistently shows that a complete course of isotretinoin at an appropriate cumulative dose provides the best chances of long-term clearance (NIH ODS).

Isotretinoin is associated with a range of side effects, many of which are dose-dependent. Common side effects include dry skin, chapped lips (cheilitis), dry eyes, dry mouth, and nosebleeds. Musculoskeletal symptoms such as joint pain and back pain can occur. Some individuals may experience hair thinning, sun sensitivity, and changes in mood. Rare but serious side effects include elevated liver enzymes, increased cholesterol and triglyceride levels, and inflammatory bowel disease. Blood tests are typically performed before and during treatment to monitor for these effects. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.

Source for this section: Sources for What are the side effects of Isotretinoin?: Jumps to this entry in the sources and references list at the end of the page.

Isotretinoin carries several serious warnings. The most significant is its severe teratogenicity, meaning it can cause severe birth defects if taken during pregnancy. Therefore, it is absolutely contraindicated in pregnant women, and strict pregnancy prevention programs (like iPLEDGE in the U.S.) are mandatory for all female patients of childbearing potential. These programs require multiple negative pregnancy tests before, during, and after treatment, and the use of two forms of contraception. There is also a warning regarding potential psychiatric effects, including depression, mood disturbance, psychosis, and, rarely, suicidal ideation. Patients should be monitored for new or worsening psychiatric symptoms. Other warnings include potential for severe skin reactions, increased intracranial pressure, visual disturbances, and hearing impairment. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.

Source for this section: Sources for Who should avoid Isotretinoin?: Jumps to this entry in the sources and references list at the end of the page.

Isotretinoin is strictly contraindicated in pregnant women and women who may become pregnant unless all conditions of a pregnancy prevention program are met. It is also contraindicated in individuals with hypersensitivity to isotretinoin or any of its excipients. Patients with severe hepatic impairment, uncontrolled hyperlipidemia, or hypervitaminosis A should not take isotretinoin. Concurrent use of tetracyclines is also a contraindication due to the risk of increased intracranial pressure. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.

Source for this section: Sources for When should Isotretinoin not be taken?: Jumps to this entry in the sources and references list at the end of the page.

Isotretinoin should not be mixed with several other medications or substances. It is critically important to avoid concomitant use with tetracycline antibiotics (e.g., doxycycline, minocycline) due to the risk of pseudotumor cerebri (benign intracranial hypertension). Vitamin A supplements should be avoided, as isotretinoin is a derivative of vitamin A, and excessive intake could lead to hypervitaminosis A. Other retinoid medications (topical or oral) should also be avoided to prevent additive toxicity. Alcohol consumption should be limited or avoided during treatment due to the potential for increased liver enzyme elevation. St. John's Wort should be avoided as it may decrease the effectiveness of hormonal contraception, which is crucial for female patients on isotretinoin. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.

Source for this section: Sources for What should you not mix with Isotretinoin?: Jumps to this entry in the sources and references list at the end of the page.

Isotretinoin is typically taken orally once or twice daily. It is crucial to take isotretinoin with a meal, as food (particularly fatty meals) significantly increases its absorption, ensuring optimal efficacy. The exact dosage and duration of treatment are user-directed and must be set by a licensed clinician based on factors such as body weight, response to treatment, and the severity of acne. A typical course of treatment lasts for several months, often 15 to 20 weeks, to achieve a cumulative dose that maximizes efficacy and minimizes relapse rates.

Source for this section: Sources for When should you take Isotretinoin?: Jumps to this entry in the sources and references list at the end of the page.

Put it into practice

Reading about Isotretinoin is the first step — DoseRoutine helps you act on it. These free tools turn what you just learned into a routine.

What interacts with Isotretinoin?

Documented interactions for Isotretinoin: the other compound, the severity and confidence of the interaction, what happens, and what to do.
Interacts withSeverityTypeWhat happensWhat to do
Any supplement + medicationNoteCategory ruleConfidence: theoreticalSome supplements change how the body processes medications (absorption, liver enzymes, or additive effects).Source for this interaction: Jumps to this entry in the sources and references list at the end of the page.Specific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist.
Any vitamin + medicationNoteCategory ruleConfidence: theoreticalCertain vitamins interact with specific medications (e.g., vitamin K with blood thinners).Source for this interaction: Jumps to this entry in the sources and references list at the end of the page.Specific pairs are checked against a licensed source; confirm with your provider.

Frequently asked questions about Isotretinoin

Isotretinoin is primarily used to treat severe, recalcitrant nodular acne that has not responded to other treatments, including oral antibiotics.

Isotretinoin is severely teratogenic, meaning it can cause severe birth defects. Strict regulations, such as the iPLEDGE program in the U.S., are in place to prevent any possibility of pregnancy during treatment due to this risk.

A typical course of isotretinoin treatment usually lasts for 15 to 20 weeks, though the exact duration and dosage are determined by a clinician based on the individual patient's response and cumulative dose target.

No, you should avoid taking vitamin A supplements while on isotretinoin. Isotretinoin is a vitamin A derivative, and combining them can lead to hypervitaminosis A, a condition caused by excessive vitamin A intake.

Yes, regular blood tests are typically required before and periodically during isotretinoin treatment to monitor for potential side effects such as elevated liver enzymes and changes in cholesterol and triglyceride levels.

Interaction risk for Isotretinoin comes from the rest of the stack: other medications, prescription medicines, hormone therapy and peptides. Because Isotretinoin is usually taken with a meal, most avoidable conflicts come from what else lands in that same window. With a reported plasma half-life near 10 hours, separating doses can change the picture as much as removing one. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Isotretinoin with no sign-up.

Isotretinoin is typically taken with a meal. Published protocols usually have it taken with food. The reported plasma half-life is about 10 hours, which is what drives how often it is redosed. Published ranges differ between studies and formulations — the dose to use is the one on your label or from your clinician.

There is no single answer for Isotretinoin plus TRT. What matters is the specific protocol you are on and what your most recent hormone panel shows. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions

Pairing Isotretinoin with peptides has to be assessed one peptide at a time, because GLP-1 agonists, secretagogues, healing peptides and melanocortins do not share an interaction profile. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.

With a plasma half-life near 10 hours, once-daily dosing is the usual pattern for Isotretinoin. It is typically taken with a meal. Most protocols have it taken with food. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps

With a plasma half-life near 10 hours, a single missed dose of Isotretinoin usually has a smaller effect on overall exposure than an irregular pattern of missed doses does. Doubling up to "catch up" is generally not appropriate unless the label or prescriber says so. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.

For Isotretinoin the useful record is the dose, the time it was actually taken, and what else was taken in the same window. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.

Isotretinoin is approved for severe recalcitrant nodular acne that has not responded to other treatments including antibiotics, and dermatologists also use it for scarring acne and some cases of rosacea and hidradenitis. It is the only acne treatment that can produce long-lasting remission after a finished course rather than only control while taken. This is educational information, not medical advice.

Because it is a potent teratogen: exposure in pregnancy causes severe craniofacial, cardiac and central nervous system malformations. The United States therefore runs the iPLEDGE risk management program, requiring registration, contraception commitments and regular pregnancy testing for anyone who can become pregnant, with prescriptions released in short intervals. This is educational information, not medical advice.

Dryness dominates: chapped lips, dry skin, dry eyes, nosebleeds and sun sensitivity are near-universal and managed with moisturizers and lip balm. Muscle aches and raised triglycerides or liver enzymes are common enough that bloodwork is monitored. An initial flare of acne in the first weeks is also typical before improvement begins. This is educational information, not medical advice.

The Cochrane review's included dose-comparison trials studied continuous low-dose (0.25–0.4 mg/kg/day), continuous conventional-dose (0.5–1 mg/kg/day), and intermittent (one week per month) oral isotretinoin regimens; the antihistamine-adjuvant trial dosed isotretinoin without specifying a fixed mg/kg figure in the abstract. Route reported: Oral capsule in all cited trials. Frequency reported: Once or twice daily depending on regimen, with one comparison arm limited to one week per month. These are amounts documented in the cited studies and labels for Isotretinoin — they are reported for reference, not a recommendation. Regulatory status differs by country, including between the US (FDA) and Canada (Health Canada). Confirm any amount with a licensed clinician before you take it.

Which studies looked at Isotretinoin?

Peer-reviewed research indexed in PubMed. Each entry links to the original record.

  1. 1.Systematic review of low-dose isotretinoin for treatment of acne vulgaris: Focus on indication, dosage, regimen, efficacy, safety, satisfaction, and follow up, based on clinical studies(opens PubMed in a new tab)Dermatol Ther · 2021 · PMID 33085149 · https://pubmed.ncbi.nlm.nih.gov/33085149/
  2. 2.Pharmacokinetics of the retinoids isotretinoin and etretinate. A comparative review.(opens PubMed in a new tab)Journal of the American Academy of Dermatology · 1982 · PMID 6461675 · https://pubmed.ncbi.nlm.nih.gov/6461675/
  3. 3.Oral Isotretinoin and Its Uses in Dermatology: A Review(opens PubMed in a new tab)Drug Des Devel Ther · 2023 · PMID 37649956 · https://pubmed.ncbi.nlm.nih.gov/37649956/
  4. 4.Acne Transcriptomics: Fundamentals of Acne Pathogenesis and Isotretinoin Treatment(opens PubMed in a new tab)Cells · 2023 · PMID 37998335 · https://pubmed.ncbi.nlm.nih.gov/37998335/

Sources cited on this page

Specific documents referenced by the numbered markers above. Each number matches the marker in the text.

  1. MedlinePlus(opens in a new tab)U.S. National Library of Medicine · medlineplus.gov/druginfo/meds/a681043.html
  2. PubChem CID 5282379(opens in a new tab)National Center for Biotechnology Information · pubchem.ncbi.nlm.nih.gov/compound/5282379

Verify at

Publisher search links for Isotretinoin. These are places to check the information — they are not citations, so they are not numbered.

DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.

What is the short answer on Isotretinoin?

Plain-text summary, safe to quote verbatim:

Isotretinoin, originally sold as Accutane and now as Absorica, Claravis and others, is an oral retinoid for severe nodular or treatment-resistant acne. It shrinks sebaceous glands and reduces oil output, and courses typically run four to six months aiming at a cumulative target.
Source: DoseRoutine — https://doseroutine.com/library/isotretinoin

Isotretinoin cheat sheet

DoseRoutine cheat sheet · Medication

Isotretinoin

Isotretinoin, originally sold as Accutane and now as Absorica, Claravis and others, is an oral retinoid for severe nodular or treatment-resistant acne. It shrinks sebaceous glands and reduces oil output, and courses typically run four to six months aiming at a cumulative target.

Evidence

Strong

1 human randomized trial and regulatory approval on file.

Studied range

The Cochrane review's included dose-comparison trials studied continuous low-dose (0.25–0.4 mg/kg/day), continuous conventional-dose (0.5–1 mg/kg/day), and intermittent (one week per month) oral isotretinoin regimens; the antihistamine-adjuvant trial dosed isotretinoin without specifying a fixed mg/kg figure in the abstract

Route

Oral capsule in all cited trials

Frequency studied

Once or twice daily depending on regimen, with one comparison arm limited to one week per month

Half-life

10–20 h

Timing

with a meal

With food

with food

Prescription only (US)Oral isotretinoin (Accutane and generics) is FDA-approved for severe recalcitrant nodular acne and is dispensed only through the iPLEDGE risk-management program because of teratogenicity

Key references

  1. Oral isotretinoin for acne (2018)
  2. Effect of antihistamine as an adjuvant treatment of isotretinoin in acne: a randomized, controlled comparative study (2014)

Studied ranges, not dosing advice. Not medical advice — talk to a clinician. doseroutine.com/library/isotretinoin

Cite this page

Using this in an article, AI answer, or research note? Please attribute:

DoseRoutine. (2026). Isotretinoin — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/isotretinoin
Canonical URL

What compounds are similar to Isotretinoin?

Others in the medication category or studied for the same goals.

Track Isotretinoin in DoseRoutine

Add it to your stack. We'll schedule doses, check interactions against everything else you take, and remind you at the right time.

Sign up free →

Latest research from DoseRoutine

Browse all DoseRoutine research updates

Track Isotretinoin in your own routine

Add Isotretinoin to your stack, get reminders at the right times, and see interaction notes with everything else you take. Free to start — no card needed.

Track Isotretinoin freeSign in